Keefe Bruyette lowered the firm’s price target on MetLife (MET) to $98 from $100 and keeps an Outperform rating on the shares.Maximize Your ...

MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite ...

MetLife Inc. closed 6.70% short of its 52-week high of $89.05, which the company reached on November 27th.

New York-based MetLife, Inc. (MET) is a financial services company that provides insurance, annuities, employee benefits, and ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look ...

Best Medical Stocks To Buy Under $20 and 10 Best Stocks to Buy and Hold For 2025. In January 2025, the US government proposed ...

It has been 32 years since WWE WrestleMania took place in Las Vegas, and the two sides are looking to make up for lost time.

MetLife Inc. closed 6.04% below its 52-week high of $89.05, which the company achieved on November 27th.

MetLife Inc. (MET) released earnings for its fourth quarter that increased from last year in line with the Street estimates. The ...

MetLife, Inc. (NYSE: MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, has provided a fourth quarter and full year 2024 financial ...